leadf
logo-loader
viewSativa Wellness Group Inc
(
AQSE:SWELCSE:SWELOTC:SCNNFFRA:484
)

Sativa Investments 'at the forefront' of developing UK medical cannabis market

Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London's Andrew Scott to discuss the NEX-based medical cannabis investor's trading and strategic update.

Sativa's this week unveiled plans to become a first-mover seed-to-consumer business in the UK.

The firm's taking its cue from Canada, which first approved the drug for medical use 18 years ago, and is now home to vertically integrated cannabis giants such as Canopy Growth (now listed in New York and worth around US$10bn).

Quick facts: Sativa Wellness Group Inc

Follow
AQSE:SWEL

Price: 3.65 GBX

Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Sativa Wellness Group' launches competitive pricing membership scheme

Sativa Wellness Group Inc (AQSE:SWEL, CSE:SWEL, OTC:SCNNF, FRA:484)'s (LON:SWEL) Geremy Thomas joins Proactive to discuss the launch of their full membership scheme through its website as well as a new competitive pricing strategy.  Under the new pricing scheme, a 30ml 20% CBD product will...

5 days, 5 hours ago

2 min read